BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8967186)

  • 1. [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].
    Ringe JD; Reginster JY; Gennari C; Hosking DJ; Meunier PJ
    Z Rheumatol; 1996; 55(4):256-9. PubMed ID: 8967186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES; Lyles KW; Singer FR; Meunier PJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Paget's disease of bone.
    Langston AL; Ralston SH
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone: experience from a centre in southern India.
    Anjali ; Thomas N; Rajaratnam S; Shanthly N; Oommen R; Seshadri MS
    J Assoc Physicians India; 2006 Jul; 54():525-9. PubMed ID: 17089899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone.
    Cremers SC; Eekhoff ME; Den Hartigh J; Hamdy NA; Vermeij P; Papapoulos SE
    J Bone Miner Res; 2003 May; 18(5):868-75. PubMed ID: 12733726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease of bone.
    Siris ES
    J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paget's disease of bone.
    Rousière M; Michou L; Cornélis F; Orcel P
    Best Pract Res Clin Rheumatol; 2003 Dec; 17(6):1019-41. PubMed ID: 15123049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paget disease of bone: therapeutic options.
    Silverman SL
    J Clin Rheumatol; 2008 Oct; 14(5):299-305. PubMed ID: 18838910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Paget's disease of bone: a survey of clinical practice in Australia.
    Walsh JP; Attewell R; Stuckey BG; Hooper MJ; Wark JD; Fletcher S; Ferrari V; Eisman JA
    Bone; 2008 Jun; 42(6):1219-25. PubMed ID: 18353737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic progress--review VII. The medical treatment of Paget's disease.
    Sheppard MC
    J Clin Hosp Pharm; 1983 Mar; 8(1):35-44. PubMed ID: 6221033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM; Au-Yeong ML; McKenna MJ
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological therapy of Paget's and other metabolic bone diseases.
    Hosking D
    Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
    Muschitz C; Feichtinger X; Haschka J; Kocijan R
    Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and pharmacologic treatment of Paget's disease.
    Hamdy RC
    Endocrinol Metab Clin North Am; 1995 Jun; 24(2):421-36. PubMed ID: 7656897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with Paget's disease of bone.
    Roux C; Dougados M
    Drugs; 1999 Nov; 58(5):823-30. PubMed ID: 10595863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Single-dose treatment of Paget's disease].
    Alexandre C
    Rev Prat; 1990 Jun; 40(17):1591-3. PubMed ID: 2363016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.